6 days ago
1
Michael Vi
- Gilead Sciences (NASDAQ:GILD) has broken ground on its Pharmaceutical Development and ManufacturingTechnical Development Center (NTDC) at the biotech's Foster City, Calif., headquarters.
- The building is part of the company's planned $32B manufacturing and R&D investments in the U.S. through 2030.
English (US) ·